Full-Time
Clinical Sales Representative
Posted on 9/16/2025
Cranial Technologies
501-1,000 employees
Manufactures cranial orthotics and runs clinics
Compensation Overview
$120k/yr
No H1B Sponsorship
Stockton, CA, USA
In Person
 Sales & Account Management (5) |
|---|
| , , , , |
- Bachelor’s Degree
- 1+ years of successful B2B, outside sales experience
- Self-Starter: Strong initiative and independence in building and managing your own territory.
- Quick Learner: Able to absorb new information quickly and apply it in diverse situations.
- Professionalism: You represent Cranial Technologies with integrity and commitment.
- Authorized to work for any employer in the U.S. (Applicants must be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment Visa at this time.)
- Engage with Pediatric Practices: Meet with pediatricians and practice staff, providing insights on diagnosing and managing plagiocephaly and sharing the benefits of Cranial Technologies’ DOC Band®.
- Promote and Educate: Conduct in-service presentations for all levels of practice staff—from pediatricians to referral coordinators—fostering a thorough understanding of our services and outcomes.
- Build and Manage a Territory: Strategically manage relationships in your assigned territory, driving patient referrals to the Cranial Technologies clinic in your territory.
- Data Analysis: Leverage data to manage and prioritize the assigned health care provider accounts in your territory efficiently and effectively.
- Experience in medical or referral-based sales is a plus
Cranial Technologies provides treatment for infant plagiocephaly using the DOC Band®, a custom cranial orthotic worn to guide skull growth. The product starts with a precise 3D scan of an infant’s head using Digital Surface Imaging® to design a helmet that gradually reshapes the skull as the baby grows. The company combines manufacturing the helmets with operating its own clinics, ensuring consistent fit, fabrication quality, and care. What sets it apart is its vertically integrated model, FDA-cleared DOC Band for plagiocephaly since 1998, and ownership of both device production and patient services, enabling scalable, standardized treatment across clinics. The goal is to expand clinics across the U.S. and into international markets, continuing to lead in a niche the company largely created while treating over 400,000 babies.
Company Size
501-1,000
Company Stage
N/A
Total Funding
N/A
Headquarters
Tempe, Arizona
Founded
1986
Simplify's Take
What believers are saying
- DOC Van mobile clinic launched in Santa Clarita weekly.
- NMPA-cleared DOC Band debuted at CIIE Shanghai November 2025.
- Expanded Irvine facility occupied July 2023 for growth.
What critics are saying
- Orthomerica's Starband grabs 40% share via pricing, partnerships.
- AAP, BMJ evidence cuts pediatrician referrals within 12 months.
- Eurazeo expansion to 120 clinics triggers 20-30% turnover.
What makes Cranial Technologies unique
- DOC Band was first FDA-cleared cranial helmet in 1998.
- Proprietary Digital Surface Imaging creates custom 3D helmets.
- Vertically integrated as manufacturer and clinic operator.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
401(k) Retirement Plan
Paid Vacation
Life Insurance
Short/Long Term Disability Insurance
Company News
Mobile clinic treats plagiocephaly weekly. **Mobile DOC Van Brings Weekly Plagiocephaly Treatment to Santa Clarita Families** Cranial Technologies has launched its first mobile clinic, the DOC Van, bringing weekly plagiocephaly evaluations and custom helmet fittings to Santa Clarita to reduce travel burdens for families. Operating every Tuesday in Valencia, the van serves infants primarily between 4 and 6 months old, offering complimentary assessments and ongoing treatment closer to home.
Cranial Technologies debuts nmpa-cleared infant head reshaping treatment in China at CIIE. SHANGHAI, Nov. 7, 2025 /PRNewswire/ - Cranial Technologies, a leading US medical device company specializing in the treatment of infant head shape conditions, officially introduced its flagship DOC Band(R) treatment in the Chinese market at the China International Import Expo (CIIE), taking place from November 5 to 10, 2025, in Shanghai. Cranial Technologies has treated over 400,000 infants across the United States and Europe. Its participation in CIIE marks a major milestone in the company's global expansion and its first entry into the Chinese market. "We are truly honored to participate in CIIE for the first time - it is one of the world's most influential platforms for global trade and innovation," said Debbie James, Chief Executive Officer of Cranial Technologies. "CIIE provides an opportunity to establish meaningful partnerships that can help bring world-class infant care solutions to more Chinese families. Our mission aligns closely with the objectives of Healthy China 2030, making this an ideal time to begin a deeper dialogue with this important market." Cranial Technologies' entry into China comes amid increasing awareness of plagiocephaly - commonly known as flat head syndrome - among newborns. Research indicates that approximately 25 percent of infants may require clinical intervention, a ratio consistent with that observed in international markets. The DOC Band(R) is the first FDA-cleared medical device designed to gently reshape an infant's head as the baby grows. Each band is custom-fitted using the company's proprietary 3D imaging and AI-based design technology to address each infant's unique cranial needs. "Each band is custom-made to meet the individual needs of every baby - like snowflakes, no two are the same," said James. Cranial Technologies has developed a dedicated e-learning platform for Chinese clinicians, supported by its American training team. "Our success relies on a combination of advanced product design and comprehensive clinical protocols," James said. The company will adopt a partnership-based business model, collaborating with local distributors, physicians, and hospitals to deliver its treatment across China. The product has received clearance from the National Medical Products Administration and will soon be available in the Chinese market. CIIE booth: Medical Equipment and Healthcare Products Hall - Booth No. 1.1B4-06 About Cranial Technologies Founded in 1986, Cranial Technologies is a global leader in the treatment of infant head shape conditions. The company developed the Doc Band(R) in 1998, the first FDA-cleared cranial orthotic for treating plagiocephaly and has since treated over 400,000 babies worldwide. www.cranialtech.com.
Three new medical suite leases have been signed at 206 Bergen Ave. in Kearny, according to a Tuesday announcement from NAI James E. Hanson.The transactions include a 4,344-square-foot lease with Pulse Vascular LLC, a 3,571-square-foot lease with Cranial Technologies Inc. and a 1,500-square-foot lease with IME Plus LLC.Hanson’s Team Lizzack-Horning, comprised of Darren Lizzack and Randy Horning, represented the landlord, 206 Bergen Avenue LLC, in each transaction.The property on Bergen Avenue is a recently upgraded, four-story, 122,205-square-foot building of medical suites featuring proximity to Route 21 and Interstate 280, as well as the New Jersey Turnpike. Formerly a surgical center with four operating rooms, the building is now suited to meet the needs of multiple health care practice types and offers tenants ample parking in a private covered garage.“Health care tenants continue to be in the market for well maintained and strategically located properties near large population centers,” Lizzack said. “206 Bergen Ave.’s history as a trusted source of health care services for the Kearny community, combined with its accessibility via both personal and public transportation, make it a highly desirable location
Cranial Technologies to expand into new space in Irvine California. Cranial Technologies to expand into new space in Irvine California.Irvine, California — According to state and local economic development sources Cranial Technologies plans to build out new space in Irvine. The company plans to occupy the new space at 114 Pacifica Suite 300 in Irvine, on or about July 1, 2023. According to the company website Founded in 1986, Cranial Technologies is the only company in the world solely dedicated to treating infants with plagiocephaly. Its our mission to provide the best possible treatment, experience and outcome for every family who seeks our care. To date, we’ve cared for approximately 175,000 babies using our proven safe and effective DOC Band cranial orthotic
NEW YORK--(BUSINESS WIRE)--Eurazeo announced it has acquired a majority stake in Cranial Technologies, the market leader in treating infant plagiocephaly.